Subscribe Us

header ads

Recents

header ads

Marine Biotechnology Market Size At Around US$ 11.7 Bn In 2032

 The marine biotechnology market would grow at a CAGR of 7.09% over the predicted time frame. The market is expected to increase in value from US$ 5.9 Bn in 2022 to US$ 11.7 Bn in 2032.

Marine Biotechnology Market Size 2023 To 2032

The on marine biotechnology Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2614

A recent report provides crucial insights along with application based and forecast information in the Global Marine biotechnology Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Marine biotechnology market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Marine biotechnology market are included as given below:

Marine biotechnology Market Key Players

  • Aker BioMarine AS
  • Aqua Biotechnology ASA
  • BASF SE
  • BioLume, Inc.
  • Biotech Marine
  • CP Kelco
  • Cyanotech Corp.
  • GlycoMar Ltd.
  • Lonza Group Ltd.
  • Marinova Pty Ltd
  • New England Biolabs Inc
  • NovaMatrix
  • Nutrex Hawaii Inc.,
  • oceanBASIS GmbH
  • PharmaMar S.A
  • Prolume Ltd
  • Royal DSM N.V
  • Sea Run Holdings, Inc.
  • SEPPIC
  • Tequesta BioVentures

Market Segments

By Source

  • Corals and sponges
  • Algae
    • Micro Algae
    • Macro Algae
  • Marine Viruses
  • Marine Fungi
  • Others

By Application

  • Aquaculture & Fishery
  • Medicine
  • Environment
  • Biofuels
  • Other

By End User

  • Medical & Pharmaceutical
  • Food Industry
  • Cosmetics Industry
  • Chemical Industry
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Report Objectives

  • To define, describe, and forecast the global marine biotechnology market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the marine biotechnology market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Marine Biotechnology Market 

5.1. COVID-19 Landscape: Marine Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Marine Biotechnology Market, By Source

8.1. Marine Biotechnology Market, by Source, 2023-2032

8.1.1 Corals and sponges

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Algae

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Marine Viruses

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Marine Fungi

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Marine Biotechnology Market, By Application

9.1. Marine Biotechnology Market, by Application, 2023-2032

9.1.1. Aquaculture & Fishery

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Medicine

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Environment

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Biofuels

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Other

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Marine Biotechnology Market, By End User 

10.1. Marine Biotechnology Market, by End User, 2023-2032

10.1.1. Medical & Pharmaceutical

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Food Industry

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Cosmetics Industry

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Chemical Industry

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Marine Biotechnology Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Source (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Source (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Source (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Source (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Source (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Source (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Source (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Source (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Source (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Source (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Source (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Source (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Source (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Source (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Source (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Source (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Source (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Source (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Source (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Source (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Source (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End User (2020-2032)

Chapter 12. Company Profiles

12.1. Aker BioMarine AS

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Aqua Biotechnology ASA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. BASF SE

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. BioLume, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Biotech Marine

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. CP Kelco

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cyanotech Corp.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. GlycoMar Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Lonza Group Ltd.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Marinova Pty Ltd

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments